Mission Statement


The Cancer Epigenetics Institute (CEI) at Fox Chase is a national hub for epigenetics study and collaboration that is focused on mechanisms promoting cancer and therapeutic resistance. CEI aims to promote fundamental discovery in cancer epigenetics, while identifying novel biomarkers and therapeutic targets. Its mission is to translate these scientific insights into a positive impact on patients by facilitating academic-to-industry and academic-to-academic partnerships.